XML 26 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
 9 Months Ended
Nov. 03, 2013
Oct. 28, 2012
Cash flows from operating activities:    
Net earnings $ 145,104,000 $ 122,996,000
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation and amortization 111,412,000 98,653,000
Loss on sale/disposal of assets 1,737,000 1,567,000
Amortization of deferred lease incentives (19,055,000) (19,785,000)
Deferred income taxes (10,722,000) (8,767,000)
Tax benefit from exercise of stock-based awards 14,393,000 14,497,000
Excess tax benefit from exercise of stock-based awards (6,617,000) (7,399,000)
Stock-based compensation expense 28,440,000 22,778,000
Changes in:    
Accounts receivable (13,498,000) (13,045,000)
Merchandise inventories (258,876,000) (134,545,000)
Prepaid catalog expenses (3,382,000) (10,157,000)
Prepaid expenses and other assets (28,251,000) (12,883,000)
Accounts payable 163,592,000 4,832,000
Accrued salaries, benefits and other current and long-term liabilities 12,017,000 (9,069,000)
Customer deposits 37,519,000 17,773,000
Deferred rent and lease incentives 13,833,000 15,866,000
Income taxes payable (38,971,000) (20,929,000)
Net cash provided by operating activities 148,675,000 62,383,000
Cash flows from investing activities:    
Purchases of property and equipment (145,236,000) (116,398,000)
Restricted cash deposits 1,772,000 (1,317,000)
Proceeds from insurance reimbursement 1,418,000 0
Other 45,000 (231,000)
Net cash used in investing activities (142,001,000) (117,946,000)
Cash flows from financing activities:    
Repurchase of common stock (216,369,000) (124,293,000)
Payment of dividends (82,030,000) (66,185,000)
Repayments of long-term obligations (1,716,000) (1,765,000)
Proceeds from exercise of stock-based awards 6,541,000 12,009,000
Tax withholdings related to stock-based awards (14,162,000) (12,327,000)
Excess tax benefit from exercise of stock-based awards 6,617,000 7,399,000
Other (42,000) (405,000)
Net cash used in financing activities (301,161,000) (185,567,000)
Effect of exchange rates on cash and cash equivalents (1,309,000) 857,000
Net decrease in cash and cash equivalents (295,796,000) (240,273,000)
Cash and cash equivalents at beginning of period 424,555,000 502,757,000
Cash and cash equivalents at end of period $ 128,759,000 $ 262,484,000